Home › Funds › Atom Investors LP › GLUE

Atom Investors LP position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

Atom Investors LP reported holding 420,953 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$5.0M, representing 0.34% of its reported portfolio and ranking #49 among its reported holdings. Atom Investors LP has disclosed GLUE holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)420.95K sh
Reported value held$5.02M
Portfolio Weight0.34%
First reportedQ4 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Atom Investors LP's GLUE position evolved

Atom Investors LP first disclosed a stake in GLUE in Q4 2025 at 137,261 shares (US$2.2M). The position peaked in Q3 2026 at 420,953 shares, worth US$5.0M. Across 4 filings, Atom Investors LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 420,953 shares valued at US$5.0M — an increase of 309,941 shares quarter over quarter.. Notable position changes include a 42% increase in Q1 2026 (shares rose 47% over the following quarter), a 43% trim in Q2 2026 (shares fell 51% over the following quarter), a 279% increase in Q3 2026 (shares fell 21% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 137.26K $2.15M New
Q1 2026 194.48K $3.20M Add
Q2 2026 111.01K $2.69M Reduce
Q3 2026 420.95K $5.02M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 59 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), Vestal Point Capital, LP (US$111.3M), BVF INC/IL (US$108.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has Atom Investors LP held GLUE?

Atom Investors LP has disclosed GLUE holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Atom Investors LP's current position in GLUE?

As of Q3 2026, Atom Investors LP holds 420.95K shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $5.02M, representing 0.34% of its reported portfolio and ranking #49.

Has Atom Investors LP been buying or selling GLUE?

In the latest 13F filing (Q3 2026), Atom Investors LP increased its position in GLUE. The position peaked in Q3 2026 at 420.95K shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, Vestal Point Capital, LP, BVF INC/IL, among 59 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.